Assenagon Asset Management’s Collegium Pharmaceutical COLL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.04M | Hold |
102,691
| – | – | ﹤0.01% | 642 |
|
|
2025
Q1 | $3.07M | Sell |
102,691
-47,897
| -32% | -$1.43M | 0.01% | 636 |
|
|
2024
Q4 | $4.31M | Sell |
150,588
-23,126
| -13% | -$663K | 0.01% | 703 |
|
|
2024
Q3 | $6.71M | Sell |
173,714
-188,423
| -52% | -$7.28M | 0.01% | 611 |
|
|
2024
Q2 | $11.7M | Buy |
362,137
+291,286
| +411% | +$9.38M | 0.03% | 385 |
|
|
2024
Q1 | $2.75M | Sell |
70,851
-274,989
| -80% | -$10.7M | 0.01% | 743 |
|
|
2023
Q4 | $10.6M | Sell |
345,840
-79,790
| -19% | -$2.46M | 0.03% | 410 |
|
|
2023
Q3 | $9.51M | Buy |
425,630
+272,565
| +178% | +$6.09M | 0.03% | 367 |
|
|
2023
Q2 | $3.29M | Sell |
153,065
-105,625
| -41% | -$2.27M | 0.01% | 578 |
|
|
2023
Q1 | $6.21M | Buy |
258,690
+125,956
| +95% | +$3.02M | 0.02% | 495 |
|
|
2022
Q4 | $3.08M | Buy |
132,734
+117,900
| +795% | +$2.73M | 0.01% | 639 |
|
|
2022
Q3 | $238K | Sell |
14,834
-35,564
| -71% | -$571K | ﹤0.01% | 1211 |
|
|
2022
Q2 | $893K | Hold |
50,398
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q1 | $1.03M | Buy |
+50,398
| New | +$1.03M | ﹤0.01% | 1008 |
|